Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

218 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Amitriptyline blocks innate immune responses mediated by toll-like receptor 4 and IL-1 receptor: Preclinical and clinical evidence in osteoarthritis and gout.
Franco-Trepat E, Alonso-Pérez A, Guillán-Fresco M, Jorge-Mora A, Crespo-Golmar A, López-Fagúndez M, Pazos-Pérez A, Gualillo O, Belén Bravo S, Gómez Bahamonde R. Franco-Trepat E, et al. Among authors: gualillo o. Br J Pharmacol. 2022 Jan;179(2):270-286. doi: 10.1111/bph.15707. Epub 2021 Dec 12. Br J Pharmacol. 2022. PMID: 34643941 Free PMC article.
Adipokines and inflammation: is it a question of weight?
Francisco V, Pino J, Gonzalez-Gay MA, Mera A, Lago F, Gómez R, Mobasheri A, Gualillo O. Francisco V, et al. Among authors: gualillo o. Br J Pharmacol. 2018 May;175(10):1569-1579. doi: 10.1111/bph.14181. Epub 2018 Apr 10. Br J Pharmacol. 2018. PMID: 29486050 Free PMC article. Review.
Role of Toll-Like Receptor 4 on Osteoblast Metabolism and Function.
Alonso-Pérez A, Franco-Trepat E, Guillán-Fresco M, Jorge-Mora A, López V, Pino J, Gualillo O, Gómez R. Alonso-Pérez A, et al. Among authors: gualillo o. Front Physiol. 2018 May 8;9:504. doi: 10.3389/fphys.2018.00504. eCollection 2018. Front Physiol. 2018. PMID: 29867550 Free PMC article. Review.
Butyrate Modulates Inflammation in Chondrocytes via GPR43 Receptor.
Pirozzi C, Francisco V, Guida FD, Gómez R, Lago F, Pino J, Meli R, Gualillo O. Pirozzi C, et al. Among authors: gualillo o. Cell Physiol Biochem. 2018;51(1):228-243. doi: 10.1159/000495203. Epub 2018 Nov 16. Cell Physiol Biochem. 2018. PMID: 30448827 Free article.
Visfatin as a therapeutic target for rheumatoid arthritis.
Franco-Trepat E, Alonso-Pérez A, Guillán-Fresco M, Jorge-Mora A, Gualillo O, Gómez-Reino JJ, Gómez Bahamonde R. Franco-Trepat E, et al. Among authors: gualillo o. Expert Opin Ther Targets. 2019 Jul;23(7):607-618. doi: 10.1080/14728222.2019.1617274. Epub 2019 May 15. Expert Opin Ther Targets. 2019. PMID: 31074669 Review.
Visfatin Connection: Present and Future in Osteoarthritis and Osteoporosis.
Franco-Trepat E, Guillán-Fresco M, Alonso-Pérez A, Jorge-Mora A, Francisco V, Gualillo O, Gómez R. Franco-Trepat E, et al. Among authors: gualillo o. J Clin Med. 2019 Aug 7;8(8):1178. doi: 10.3390/jcm8081178. J Clin Med. 2019. PMID: 31394795 Free PMC article. Review.
Caffeine, a Risk Factor for Osteoarthritis and Longitudinal Bone Growth Inhibition.
Guillán-Fresco M, Franco-Trepat E, Alonso-Pérez A, Jorge-Mora A, López-Fagúndez M, Pazos-Pérez A, Gualillo O, Gómez R. Guillán-Fresco M, et al. Among authors: gualillo o. J Clin Med. 2020 Apr 18;9(4):1163. doi: 10.3390/jcm9041163. J Clin Med. 2020. PMID: 32325753 Free PMC article. Review.
218 results